Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Reasons AbbVie Is a Better Bargain Than You Might Think


At first glance, the picture for AbbVie (NYSE: ABBV) looks bad. The company's top-selling drug that generated over half of the company's total revenue in the past has lost patent exclusivity in Europe and will do so in the U.S. within the next three years. Last year, while the overall market skyrocketed AbbVie's shares fell 4%.

But I think that AbbVie is a much better bargain right now than you might think. Here are three reasons why that's the case.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments